At IRIDIA, I perform Oxford Nanopore sequencing on the PromethION platform and support the development of DNA-based authentication products. I optimize high-throughput DNA amplification workflows and contribute to R&D protocol development.
At ILLUMINA, I supported development of the TruSight Oncology Comprehensive assay through DNA/RNA extraction, library preparation, sequencing, and assay validation. I operated NextSeq and NovaSeq platforms, and used ddPCR to support an accuracy validation study for an FDA PMA submission.

